Hereditary Breast and Ovarian Cancer Risk and Prevention

Multigenerational Asian women, stock photo

Women who inherit a mutation in BRCA1 or BRCA2 have an increased risk of getting breast or ovarian cancer at an early age, developing breast cancer in both breasts and/or developing more than one type of cancer during their lifetime. Men who inherit these mutations have a higher risk for developing male breast cancer, prostate cancer and other cancers.

The Society of Gynecologic Oncology recommends that all women who have a diagnosis of ovarian/fallopian tube cancer undergo genetic counseling and testing. The goal of risk assessment is to prevent cancer either through a surgical procedure or chemoprevention medications, or to detect it at an early stage.

Our Hereditary Breast and Ovarian Cancer Risk and Prevention Clinic offers personalized risk assessment and prevention recommendations for patients and families who may be at increased risk for developing breast and/or ovarian cancer due to genetic factors. Our services include:

Breast and ovarian cancer risk assessment and genetic testing
Cancer prevention counseling and strategies
High-risk breast cancer screening and surveillance, including breast MRI
Ovarian cancer screening and prevention
Coordinated care for individuals with an inherited mutation that increases the risk of breast, ovarian and/or other cancers

Assessing Risk

Evaluation and risk assessment are offered for individuals or families who have the following in their medical history:

A personal history of:

Early onset breast cancer (before the age of 50; or, if type of breast cancer is triple negative, then before the age of 60)
Bilateral breast cancer
Breast, ovarian, thyroid or endometrial cancer
Male breast cancer
Ovarian or fallopian tube cancer
Breast and/or ovarian cancer and ethnic background with an increased risk of inherited forms of breast cancer (for example, Ashkenazi Jewish ancestry)

A family history of:

Two or more close relatives with breast and/or ovarian cancer and/or pancreatic cancer and/or aggressive prostate cancer
CDH1 gene mutations (hereditary diffuse gastric cancer syndrome)

Appointments

Call 1-855-702-8222 or complete the form below to request an appointment for hereditary breast and ovarian cancer risk assessment.

After Breast Cancer, Bronzeville Woman Triumphs as a Bodybuilder

Breast cancer with a genetic mutation derailed Erica Langley's plans to become a bodybuilder. But after an aggressive, personalized treatment plan, she conquered both cancer and her bodybuilding competition.

View Langley's story

breast cancer survivor and bodybuilding champion Erica Langley

Breast & Ovarian Cancer Risk & Prevention Physician Team

Olufunmilayo I. Olopade, MD

Hematology and Oncology (Cancer)

Nita Karnik Lee, MD, MPH

Gynecologic Oncology (Gynecologic Cancer)

Ernst Lengyel, MD, PhD

Gynecologic Oncology (Gynecologic Cancer)

Iris Romero, MD, MS

Obstetrics and Gynecology (OB/GYN)

S. Diane Yamada, MD

Gynecologic Oncology (Gynecologic Cancer)

Request an Appointment

We are currently experiencing a high volume of inquiries, leading to delayed response times. For faster assistance, please call 1-855-702-8222 to schedule your appointment.

If you have symptoms of an urgent nature, please call your doctor or go to the emergency room immediately.

For Referring Physicians

To refer a patient, please call UCM Physician Connect at 1-800-824-2282.

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.

* Indicates required field